Why People Relapse Even When They Really Want to Stop
DeBinge opioid transition: When travelling to DeBinge in The Bahamas for OLANI treatment, there is no requirement to complete a separate opioid-free waiting window before arrival. DeBinge uses a medically supervised 4-to-5-day buprenorphine transition. Buprenorphine is introduced to bridge the patient away from full-agonist opioids, stabilised and tapered over the first several days, and the O’Neil Long-Acting Naltrexone Implant is typically inserted around day 4 or 5 while buprenorphine is still being tapered. The planned overlap continues as buprenorphine clears and the implant gradually releases naltrexone. This pathway is clinician-supervised because mistimed naltrexone exposure can precipitate withdrawal.
Based on DeBinge’s clinical experience in The Bahamas since 2018, the implant typically provides its strongest craving and relapse-prevention support on average 9 months, while clinically meaningful opioid-receptor blockade may persist for longer, in some patients up to about 15 months. This longer blockade may continue to reduce opioid effects and overdose risk.
Ongoing recovery: The implant is not a cure. The DeBinge programme includes a full year of professional counselling after implantation to address the behavioural and psychological side of addiction.
Someone can sincerely want to stop using opioids, understand what addiction has cost them, complete detox or rehab, and still experience a return to use. Motivation matters, but opioid use disorder involves more than a conscious decision about whether to take a drug.
Repeated opioid use can affect brain and behaviour in ways that make cravings, learned drug cues, stress responses and compulsive patterns difficult to control. A person may also return to the same people, places, pain, mental-health symptoms or stressful circumstances associated with previous opioid use.
Relapse therefore does not automatically mean someone never wanted recovery. It can mean that motivation was not sufficiently protected by treatment, medication, environmental changes, coping strategies, continuing care and a plan for periods when risk suddenly increases.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an evidence-informed educational resource and is awaiting formal clinical approval. Until formal review has been completed, it should not be represented as medically reviewed.
View Dr Fergus Law’s professional profile
Why Motivation Alone May Not Be Enough
Addiction is sometimes described as though recovery comes down to one question: does the person really want to stop?
That question is too simple.
SAMHSA explains that addiction is a complex disorder that changes the brain and can make stopping difficult even for people who genuinely want to quit.
CDC diagnostic criteria for opioid use disorder also include a persistent desire or unsuccessful efforts to cut down or control opioid use. In other words, wanting to stop but struggling to do so is itself consistent with how opioid use disorder can present.
“I do not want to keep living like this” and “I am experiencing a powerful urge to use an opioid right now.”
Treatment aims to reduce the gap between those two states.
In This Guide
- Why relapse is not simply weak willpower
- How repeated opioid use changes behaviour
- Why people and places trigger cravings
- Why stress can increase relapse risk
- Why cravings can overpower intentions
- Pain and opioid relapse
- Mental health and relapse
- Why environment matters
- Why relapse can occur after rehab
- How medication can help
- Turning motivation into a relapse-prevention plan
- What to do if opioid use returns
- What families should understand
- Frequently asked questions
- Clinical sources
Relapse Is Not Simply Evidence of Weak Willpower
Motivation is important in recovery. People make decisions every day that support or weaken their treatment.
But describing relapse entirely as a failure of willpower ignores what is known about opioid use disorder.
Repeated drug exposure can alter brain systems involved in reward, learning, stress and behavioural control. These changes can persist after someone stops using drugs.
“I Want to Stay Off Opioids”
The person may genuinely understand the consequences of previous opioid use and be strongly motivated to remain in recovery.
“Something Has Triggered an Urge”
A person, place, emotion, smell, memory or opportunity may activate an opioid-related response before the person has fully processed what is happening.
“I Need Relief Now”
Pain, panic, conflict or severe emotional distress can narrow attention toward immediate relief rather than longer-term goals.
“What Happens Next?”
Medication, coping strategies, support, environmental changes and rapid treatment contact can help interrupt the pathway toward opioid use.
How Can Opioid Use Continue to Influence Behaviour After Someone Stops?
Addiction involves learning as well as pharmacology.
If opioid use repeatedly follows certain situations, the brain can begin associating those situations with the expected effects of the drug.
Those associations may remain relevant after detox or rehab.
Trigger
Stress, pain, a person, location or emotion appears.
Association
The brain has previously connected that situation with opioid use.
Craving
Thoughts, urges or physical reactions related to opioids may increase.
Access
The person may begin contacting someone, travelling somewhere or searching for opioids.
Return to Use
Without interruption, the sequence can progress toward opioid use.
Relapse prevention tries to interrupt this sequence earlier, before the person reaches the final step.
Why Can People, Places and Memories Trigger Opioid Cravings?
NIDA describes drug-related cues as people, places, things, moods and other stimuli that can become associated with drug experiences.
These learned cues may trigger craving or drug-seeking responses even when the person consciously wants to remain abstinent.
A Person
A former supplier, using partner or social group may become associated with opioid availability.
A Place
A particular street, house, hotel, neighbourhood or route may be linked with previous opioid use.
An Emotion
Loneliness, anger, fear, boredom or shame may have repeatedly preceded opioid use.
Money
Payday or sudden access to cash may have been repeatedly associated with obtaining opioids.
A Physical Sensation
Pain, insomnia or physical discomfort can reactivate thoughts about opioid relief.
A Memory
Remembering previous opioid effects may itself contribute to craving or drug-seeking thoughts.
It means the relapse-prevention plan needs a prepared response to situations that repeatedly increase risk.
Why Can Stress Increase Relapse Risk?
Stress is a well-recognised relapse trigger.
Someone may be committed to recovery when calm, supported and rested, but make very different decisions during intense conflict, financial pressure, grief, insomnia or emotional distress.
NIDA identifies psychological stress, family problems, psychiatric illness, pain and environmental cues as factors that can trigger intense cravings and make sustained abstinence more difficult.
Examples can include:
- a relationship breakdown;
- family conflict;
- job loss;
- financial problems;
- bereavement;
- housing instability;
- legal problems;
- severe insomnia;
- physical pain;
- depression or anxiety;
- trauma-related symptoms.
Effective relapse prevention therefore includes plans for stressful events rather than assuming recovery will always occur under ideal conditions.
Why Can Opioid Cravings Feel Stronger Than Someone’s Long-Term Intention?
A long-term goal and an immediate craving operate on very different timescales.
The person may want health, family stability, employment and long-term recovery. A craving, however, can create an immediate urge for relief or opioid effects.
During an intense craving, attention may become increasingly focused on the drug.
| Long-Term Recovery Goal | Immediate High-Risk State |
|---|---|
| “I want my life back.” | “I need relief from this feeling right now.” |
| “I don’t want to overdose.” | “I’ll only use once.” |
| “I don’t want to hurt my family.” | “Nobody needs to know.” |
| “I know what opioids did to me.” | “This time I can control it.” |
These examples do not describe every person’s experience. They illustrate why a relapse-prevention plan should be designed for moments when judgment is under pressure.
Pain Can Reconnect Someone With Previous Opioid Use
Some people first encounter opioids through treatment for an injury, surgery or chronic pain.
If pain continues after addiction treatment, simply telling the person not to use opioids does not address the underlying problem.
Pain may also act as a learned cue because opioids were previously associated with relief.
People with opioid use disorder and ongoing pain should discuss treatment with appropriately qualified clinicians who understand both conditions.
Untreated Mental-Health Problems Can Make Recovery Harder
Depression, anxiety, trauma-related symptoms and severe sleep disturbance may contribute to relapse risk for some people.
Someone may have used opioids partly to escape emotional distress or to change how they felt.
If that distress remains untreated after detox or rehab, the original motivation to use opioids may reappear.
Depression
Hopelessness, loss of interest and isolation may interfere with treatment engagement and recovery routines.
Anxiety
Severe anxiety or panic may increase urges to seek immediate relief.
Trauma
Trauma reminders and emotional distress may become powerful relapse triggers for some people.
Sleep Problems
Persistent insomnia can worsen mood, coping and decision-making during recovery.
This does not mean every person with opioid use disorder has a separate mental-health diagnosis. It means relevant psychiatric and psychological needs should be assessed rather than ignored.
The Environment Can Support Recovery or Repeatedly Challenge It
A person may leave detox or rehab highly motivated and return to exactly the same environment in which opioid use developed.
That environment may still contain:
- previous suppliers;
- friends who continue to use opioids;
- easy access to substances;
- relationship conflict;
- unstable housing;
- long periods of isolation;
- financial pressure;
- untreated pain;
- little daily structure;
- limited access to treatment.
Motivation is easier to protect when recovery does not require resisting the same high-risk environment every hour of every day.
Why Can Someone Relapse After Detox or Rehab?
Structured treatment can temporarily remove many of the pressures associated with everyday life.
Rehab may provide regular meals, appointments, counselling, limited access to drugs, daily structure and separation from previous opioid networks.
Leaving treatment removes much of that external structure at once.
Restricted Drug Access
Opioids may be physically unavailable or much harder to obtain.
Built-In Structure
The day may already include therapy, meals, activities and support.
Real-Life Triggers Return
Stress, work, relationships, money, pain and previous social contacts may return immediately.
This is why treatment discharge should be viewed as a transition rather than the end of care.
Medication Can Help Treat Opioid Use Disorder Instead of Relying on Motivation Alone
FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone.
They work differently.
Buprenorphine
Can suppress withdrawal and reduce opioid cravings as part of ongoing treatment.
Methadone
Can reduce opioid withdrawal and cravings and support continuing OUD treatment.
Naltrexone
Blocks opioid receptors and can reduce or prevent expected opioid effects while sufficient medication levels are present.
CDC states that medication treatment for opioid use disorder is associated with reduced overdose risk and overall mortality.
CDC also advises that detoxification by itself, without medications for OUD, is not recommended because of increased risks of returning to opioid use, overdose and overdose death.
Read the full comparison: Medication for Opioid Relapse Prevention: What Are the Options? .
Where Can Naltrexone Fit?
Naltrexone is an opioid receptor antagonist.
While adequate medication levels are present, it can block or substantially reduce expected opioid effects.
For appropriately selected patients who have completed the necessary opioid-free preparation, antagonist treatment may add a pharmacological barrier between an impulse to use opioids and the expected opioid effect.
Motivation, counselling, mental-health care, environmental changes and continuing recovery planning can still be important.
Long-Acting Naltrexone
Longer-acting formulations may reduce reliance on repeated medication-taking decisions, which can be relevant when adherence is an important vulnerability.
Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States. DeBinge treatment involving long-acting implant-based naltrexone takes place in Nassau, The Bahamas following individual clinical assessment.
Learn more: Long-Acting Naltrexone Implant .
How Can Someone Protect the Decision to Stop?
Motivation becomes more durable when it is supported by systems that still work during a difficult day.
Treat opioid use disorder
Discuss evidence-based medication and continuing treatment rather than relying on detox alone.
Identify predictable triggers
Map the people, places, emotions, pain, money situations and times of day repeatedly associated with opioid use.
Prepare for cravings
Decide what to do, whom to call and where to go before a strong craving appears.
Treat mental-health problems
Address depression, anxiety, trauma symptoms, insomnia or other clinically relevant problems.
Address pain properly
Build an appropriate pain-treatment strategy if pain has previously contributed to opioid use.
Change the recovery environment
Reduce unnecessary exposure to previous suppliers, opioid-using networks and highly conditioned locations where possible.
Create daily structure
Plan treatment, sleep, work, meaningful activity and vulnerable periods rather than relying on motivation during long unstructured days.
Keep naloxone available
Where opioid exposure remains possible, naloxone and overdose-response education should remain part of the safety plan.
Respond early when risk changes
Increasing cravings, missed treatment or renewed contact with opioid networks should trigger action before opioid use occurs.
For the complete framework, read: How to Prevent Opioid Relapse After Detox or Rehab .
If Opioid Use Returns, Do Not Turn One Episode Into a Judgment About the Person
A return to opioid use does not establish that recovery is impossible.
It does, however, mean the current situation needs to be reassessed.
Important questions include:
- Was medication being taken or received as planned?
- Were cravings increasing?
- Did a specific person or place trigger the episode?
- Was pain involved?
- Had depression, anxiety or sleep deteriorated?
- Had treatment appointments been missed?
- Had alcohol or other substance use increased?
- Was the person in contact with previous opioid suppliers?
- Was the recovery environment becoming unstable?
Opioid tolerance can decrease during abstinence. If overdose is suspected, administer naloxone if available and contact emergency services immediately.
Why a Return to Opioid Use After Abstinence Can Be Especially Dangerous
Opioid tolerance may decline after detox, rehab or another period of abstinence.
A person may remember how much opioid they previously used while their current body no longer tolerates that amount in the same way.
The illicit drug supply may also contain fentanyl or other potent substances in unpredictable quantities.
Read: Opioid Tolerance After Detox: Why Overdose Risk Can Increase .
What Should Families Understand About Relapse and Motivation?
Families may struggle to understand how someone who seemed desperate to stop could later use opioids again.
This can easily turn into statements such as “You obviously didn’t want recovery badly enough.”
That conclusion may miss important clinical information.
Motivation Can Be Genuine
A person can sincerely want recovery and still experience intense cravings or compulsive drug-seeking responses.
Risk Can Change Quickly
Stress, pain, contact with a supplier or sudden access to opioids can change the situation rapidly.
Look for What Changed
Ask about treatment, cravings, sleep, mental health, medication, pain and environmental triggers.
Keep Emergency Protection Available
Family members can learn to recognise opioid overdose and administer naloxone.
Build a Relapse-Prevention System That Works on Difficult Days
Long-term recovery should not depend on someone successfully resisting every craving using motivation alone. Medication, treatment engagement, craving management, trigger planning, mental-health care, family support, naloxone and early intervention can all provide additional layers of protection.
Discuss a Treatment Plan Designed to Reduce Reliance on Daily Willpower
DeBinge provides addiction treatment in Nassau, The Bahamas. For appropriately assessed patients, treatment may include long-acting implant-based naltrexone alongside counselling and continuing relapse-prevention planning.
A longer-acting antagonist approach may reduce reliance on repeated medication-taking decisions, but it does not replace counselling, mental-health care, trigger management or wider recovery support.
Treatment suitability depends on current opioid exposure, completion of an appropriate opioid-free period, medical history, previous treatment, medications and individual recovery needs.
Why People Relapse Even When They Want to Stop: FAQs
Why do people relapse if they really want to stop?
Motivation is only one part of recovery. Opioid use disorder can involve persistent cravings, conditioned triggers, stress responses and patterns of compulsive use. Environmental exposure, pain, mental-health symptoms and gaps in treatment can also increase relapse risk.
Does relapse mean someone did not really want recovery?
No. A person can genuinely want recovery and still experience a return to opioid use. Relapse should prompt assessment of treatment, cravings, medication, mental health, pain, environmental triggers and other factors that may have increased risk.
Is opioid addiction just a lack of willpower?
No. Opioid use disorder is a diagnosable medical condition. Repeated opioid exposure can affect brain and behaviour in ways that make controlling drug use difficult even when a person wants to stop.
Can opioid cravings continue after detox?
Yes. Ending acute withdrawal does not automatically eliminate cravings, learned drug cues or environmental triggers.
Why can seeing certain people trigger relapse?
People repeatedly associated with obtaining or using opioids can become conditioned drug cues. Encountering those cues may reactivate opioid-related thoughts or cravings.
Can stress cause opioid relapse?
Stress can increase relapse vulnerability. Family conflict, financial pressure, pain, psychiatric symptoms, housing problems and other stressors may intensify cravings or reduce coping capacity.
Can someone relapse after completing rehab?
Yes. Rehab may temporarily remove many triggers and provide substantial structure, but the person may encounter previous stressors, drug cues and access to opioids after returning home. Continuing care is therefore important.
Can medication help prevent opioid relapse?
FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone. Medication treatment is associated with important benefits and should be discussed according to individual clinical circumstances.
Does naltrexone remove the desire to use opioids?
Naltrexone can reduce cravings for some patients, but it does not guarantee that opioid cravings or drug-seeking thoughts disappear. Its defining pharmacological action is opioid receptor blockade.
What should someone do when relapse warning signs appear?
Act early. Contact the treatment team, review medication and counselling, reduce exposure to triggers, use the established craving-response plan and strengthen recovery support before opioid use occurs.
What should happen if someone uses opioids again?
Address overdose safety first. If overdose is suspected, administer naloxone if available and contact emergency services. After immediate safety is addressed, reconnect with treatment promptly and review what contributed to the return to use.
Are naltrexone implants FDA-approved in the United States?
No. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.
Evidence Used in This Guide
SAMHSA — What Is Substance Use Disorder?
SAMHSA explains why addiction is not simply a lack of willpower and how persistent changes associated with addiction can make quitting difficult even when someone wants to stop.
CDC — Opioid Use Disorder: Diagnosis
CDC’s description of diagnostic criteria for OUD, including craving and persistent desire or unsuccessful efforts to reduce or control opioid use.
NIDA — Principles of Drug Addiction Treatment
NIDA’s evidence-based discussion of persistent drug-related brain changes, cravings, stress, pain, psychiatric illness and environmental cues that can contribute to relapse.
CDC — Treatment of Opioid Use Disorder
CDC patient information describing opioid use disorder as a chronic and relapsing condition and outlining medication and behavioural treatment approaches.
CDC — Opioid Use Disorder: Treating
Clinical guidance on medications for OUD and why detoxification alone is not recommended because of increased risks of return to opioid use, overdose and overdose death.
CDC — Recovery Is Possible
CDC guidance describing medication, counselling, psychosocial support and supportive social networks and environments as components that may support opioid recovery.
Relapse risk is individual and cannot be predicted from a single trigger, behaviour or online article. Clinical recommendations and treatment options can also change over time.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an educational resource concerning opioid relapse, cravings, conditioned triggers, motivation and continuing treatment for opioid use disorder. It is awaiting formal clinical approval.
View Dr Fergus Law’s professional profile
This Article Does Not Predict Whether Someone Will Relapse
This page provides general educational information. It does not diagnose opioid use disorder, determine individual relapse risk or recommend a particular treatment or medication for a specific person.
A history of relapse does not establish that treatment cannot work, and periods of recovery should not be interpreted according to one universal timeline.
Do not abruptly stop methadone, buprenorphine, naltrexone or another prescribed medication based on this article.
Naltrexone requires appropriate opioid-free preparation before initiation. Starting naltrexone while significant opioid physical dependence remains can precipitate withdrawal.
If someone cannot be awakened, has very slow or stopped breathing, or opioid overdose is suspected, administer naloxone if available and contact local emergency services immediately.
DeBinge is located in Nassau, The Bahamas. We do not operate a treatment facility in the United States. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.